{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:56:29Z","timestamp":1781232989492,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Nanjing Health Science and Technology Development Special fund project","award":["YKK22209"],"award-info":[{"award-number":["YKK22209"]}]},{"name":"Wu Jieping Medical Foundation Special Project for Digestive and Urogenital Tumors"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04805-6","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:37:03Z","timestamp":1777261023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-551b-5p deficiency associates with malignant phenotypes in gastric cancer: potential mediation by TRAF6"],"prefix":"10.1186","volume":"26","author":[{"given":"Luyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peichen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianchi","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"4805_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"4805_CR2","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1038\/s41388-021-01786-6","volume":"40","author":"L Mao","year":"2021","unstructured":"Mao L, et al. EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis. Oncogene. 2021;40:3610\u201323.","journal-title":"Oncogene"},{"key":"4805_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344.","journal-title":"Nature"},{"key":"4805_CR4","doi-asserted-by":"crossref","unstructured":"Chaithongyot S, Jantaree P, Sokolova O, Naumann M. NF-\u03baB in Gastric Cancer Development and Therapy. Biomedicines. 202;9.","DOI":"10.3390\/biomedicines9080870"},{"key":"4805_CR5","doi-asserted-by":"publisher","first-page":"20218","DOI":"10.18632\/aging.203387","volume":"13","author":"D Chen","year":"2021","unstructured":"Chen D, Liu Q, Cao G. ERCC6L promotes cell growth and metastasis in gastric cancer through activating NF-\u03baB signaling. Aging. 2021;13:20218\u201328.","journal-title":"Aging"},{"key":"4805_CR6","doi-asserted-by":"publisher","first-page":"728393","DOI":"10.3389\/fonc.2021.728393","volume":"11","author":"S Chen","year":"2021","unstructured":"Chen S, et al. MiR-199b-5p Promotes Gastric Cancer Progression by Regulating HHIP Expression. Front Oncol. 2021;11:728393.","journal-title":"Front Oncol"},{"key":"4805_CR7","doi-asserted-by":"crossref","unstructured":"Xu T, et al. MiR-200b Suppresses Gastric Cancer Cell Migration and Invasion by Inhibiting NRG1 through ERBB2\/ERBB3 Signaling. J Oncol. 2021;2021:4470778.","DOI":"10.1155\/2021\/4470778"},{"key":"4805_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92\u2013105.","journal-title":"Genome Res"},{"key":"4805_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5152\/tjg.2019.17875","volume":"30","author":"SY Bai","year":"2019","unstructured":"Bai SY, et al. Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer. Turk J Gastroenterol. 2019;30:415\u20139.","journal-title":"Turk J Gastroenterol"},{"key":"4805_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2018.01.032","volume":"418","author":"H Yuan","year":"2018","unstructured":"Yuan H, et al. Molecular mechanisms of lncRNA SMARCC2\/miR-551b-3p\/TMPRSS4 axis in gastric cancer. Cancer Lett. 2018;418:84\u201396.","journal-title":"Cancer Lett"},{"key":"4805_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.biopha.2015.11.002","volume":"77","author":"J Jin","year":"2016","unstructured":"Jin J, Shen X, Chen L, Bao LW, Zhu LM. TMPRSS4 promotes invasiveness of human gastric cancer cells through activation of NF-\u03baB\/MMP-9 signaling. Biomed Pharmacother. 2016;77:30\u20136.","journal-title":"Biomed Pharmacother"},{"key":"4805_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1756-9966-31-81","volume":"31","author":"YS Sun","year":"2012","unstructured":"Sun YS, Ye ZY, Qian ZY, Xu XD, Hu JF. Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients. J Exp Clin Cancer Res. 2012;31:81.","journal-title":"J Exp Clin Cancer Res"},{"key":"4805_CR13","doi-asserted-by":"publisher","first-page":"122916","DOI":"10.1016\/j.lfs.2024.122916","volume":"353","author":"K Wang","year":"2024","unstructured":"Wang K, et al. BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6\/NF-\u03baB\/FGF18 through m6A modification. Life Sci. 2024;353:122916.","journal-title":"Life Sci"},{"key":"4805_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.prp.2015.11.005","volume":"212","author":"F Han","year":"2016","unstructured":"Han F, Zhang L, Qiu W, Yi X. TRAF6 promotes the invasion and metastasis and predicts a poor prognosis in gastric cancer. Pathol Res Pract. 2016;212:31\u20137.","journal-title":"Pathol Res Pract"},{"key":"4805_CR15","doi-asserted-by":"crossref","unstructured":"Yang M, et al. TRAF6 Promotes Gastric Cancer Cell Self-Renewal, Proliferation, and Migration. Stem Cells Int. 2020;2020:3296192.","DOI":"10.1155\/2020\/3296192"},{"key":"4805_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/978-0-387-70630-6_10","volume":"597","author":"JY Chung","year":"2007","unstructured":"Chung JY, Lu M, Yin Q, Lin SC, Wu H. Molecular basis for the unique specificity of TRAF6. Adv Exp Med Biol. 2007;597:122\u201330.","journal-title":"Adv Exp Med Biol"},{"key":"4805_CR17","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.1158\/0008-5472.CAN-13-0370","volume":"73","author":"H Sun","year":"2013","unstructured":"Sun H, et al. TRAF6 upregulates expression of HIF-1\u03b1 and promotes tumor angiogenesis. Cancer Res. 2013;73:4950\u20139.","journal-title":"Cancer Res"},{"key":"4805_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"issue":"1","key":"4805_CR19","first-page":"1","volume":"1","author":"J Cheng","year":"2025","unstructured":"Cheng J, He Z, Jing J, Liu Y, Zhang H. Integrating machine learning and multi-omics to identify key SUMOylation molecular signatures in sarcoma. Life Conflux. 2025;1(1):1\u201323.","journal-title":"Life Conflux"},{"key":"4805_CR20","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47:D900\u20138.","journal-title":"Nucleic Acids Res"},{"key":"4805_CR21","doi-asserted-by":"publisher","first-page":"e1000217","DOI":"10.1371\/journal.pcbi.1000217","volume":"4","author":"E Lee","year":"2008","unstructured":"Lee E, Chuang HY, Kim JW, Ideker T, Lee D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol. 2008;4:e1000217.","journal-title":"PLoS Comput Biol"},{"key":"4805_CR22","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1172\/JCI91095","volume":"127","author":"J Jeschke","year":"2017","unstructured":"Jeschke J, et al. DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. J Clin Invest. 2017;127:3090\u2013102.","journal-title":"J Clin Invest"},{"key":"4805_CR23","doi-asserted-by":"publisher","first-page":"100293","DOI":"10.1016\/j.patter.2021.100293","volume":"2","author":"\u00d3 Lapuente-Santana","year":"2021","unstructured":"Lapuente-Santana \u00d3, van Genderen M, Hilbers PAJ, Finotello F, Eduati F. Interpretable systems biomarkers predict response to immune-checkpoint inhibitors. Patterns (N Y). 2021;2:100293.","journal-title":"Patterns (N Y)"},{"key":"4805_CR24","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu L, et al. A Web Server for Resolving Tumor Immunophenotype Profiling. Cancer Res. 2018;78:6575\u201380.","journal-title":"Cancer Res"},{"key":"4805_CR25","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 2021;49:D1420\u201330.","journal-title":"Nucleic Acids Res"},{"key":"4805_CR26","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51:D1425\u201331.","journal-title":"Nucleic Acids Res"},{"key":"4805_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol. 2022;19:237\u201353.","journal-title":"Nat Rev Clin Oncol"},{"key":"4805_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019;51:27\u201341.","journal-title":"Immunity"},{"key":"4805_CR29","doi-asserted-by":"publisher","first-page":"7570","DOI":"10.1002\/jcb.27067","volume":"119","author":"R Ranjbar","year":"2018","unstructured":"Ranjbar R, Hesari A, Ghasemi F, Sahebkar A. Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection. J Cell Biochem. 2018;119:7570\u20136.","journal-title":"J Cell Biochem"},{"key":"4805_CR30","doi-asserted-by":"publisher","first-page":"45725","DOI":"10.18632\/oncotarget.17392","volume":"8","author":"G Song","year":"2017","unstructured":"Song G, et al. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression. Oncotarget. 2017;8:45725\u201335.","journal-title":"Oncotarget"},{"key":"4805_CR31","first-page":"2912","volume":"11","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. Expression of miR-551b and its effect on apoptosis in human gastric carcinoma. Int J Clin Exp Pathol. 2018;11:2912\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"4805_CR32","first-page":"5741","volume":"23","author":"HY Sun","year":"2019","unstructured":"Sun HY, et al. Decreased expression of miR-551b predicts poor prognosis and promotes tumorigenesis by targeting PTP4A3 in human colorectal cancer. Eur Rev Med Pharmacol Sci. 2019;23:5741\u201351.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4805_CR33","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s13577-022-00753-x","volume":"35","author":"Z Yang","year":"2022","unstructured":"Yang Z, et al. Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31\/Akt signaling. Hum Cell. 2022;35:1797\u2013812.","journal-title":"Hum Cell"},{"key":"4805_CR34","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1111\/jcmm.14312","volume":"23","author":"W Chang","year":"2019","unstructured":"Chang W, Wang Y, Li W, Shi L, Geng Z. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1. J Cell Mol Med. 2019;23:4945\u201354.","journal-title":"J Cell Mol Med"},{"key":"4805_CR35","doi-asserted-by":"publisher","first-page":"140810","DOI":"10.1016\/j.ijbiomac.2025.140810","volume":"304","author":"J Pang","year":"2025","unstructured":"Pang J, et al. Molecular mechanism and role of miRNA-155 ribonucleic acid in podocyte apoptosis in lupus nephritis: SOCS1 protein expression regulates JAK\/STAT pathway transduction. Int J Biol Macromol. 2025;304:140810.","journal-title":"Int J Biol Macromol"},{"key":"4805_CR36","doi-asserted-by":"publisher","first-page":"111438","DOI":"10.1016\/j.intimp.2023.111438","volume":"127","author":"H Wei","year":"2024","unstructured":"Wei H, et al. miR-148a and miR-551b-5p regulate inflammatory responses via regulating autophagy in acute pancreatitis. Int Immunopharmacol. 2024;127:111438.","journal-title":"Int Immunopharmacol"},{"key":"4805_CR37","doi-asserted-by":"publisher","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang B, Lang X, Li X. The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Front Oncol. 2022;12:1023177.","journal-title":"Front Oncol"},{"key":"4805_CR38","doi-asserted-by":"publisher","first-page":"20741","DOI":"10.18632\/oncotarget.15119","volume":"8","author":"X Wu","year":"2017","unstructured":"Wu X, et al. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2\/STAT3 signaling pathway. Oncotarget. 2017;8:20741\u201350.","journal-title":"Oncotarget"},{"key":"4805_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41419-022-04747-3","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu M, et al. RBMS1 promotes gastric cancer metastasis through autocrine IL-6\/JAK2\/STAT3 signaling. Cell Death Dis. 2022;13:287.","journal-title":"Cell Death Dis"},{"key":"4805_CR40","doi-asserted-by":"publisher","first-page":"12425","DOI":"10.1073\/pnas.1106645108","volume":"108","author":"M Jinushi","year":"2011","unstructured":"Jinushi M, et al. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem\/initiating cells. Proc Natl Acad Sci U S A. 2011;108:12425\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4805_CR41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12885-017-3310-9","volume":"17","author":"N S\u00e1nchez-Zauco","year":"2017","unstructured":"S\u00e1nchez-Zauco N, et al. Circulating blood levels of IL-6, IFN-\u03b3, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study. BMC Cancer. 2017;17:384.","journal-title":"BMC Cancer"},{"key":"4805_CR42","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1038\/sj.onc.1209464","volume":"25","author":"HH Yeh","year":"2006","unstructured":"Yeh HH, Lai WW, Chen HH, Liu HS, Su WC. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene. 2006;25:4300\u20139.","journal-title":"Oncogene"},{"key":"4805_CR43","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41419-019-2131-y","volume":"10","author":"W Li","year":"2019","unstructured":"Li W, et al. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer. Cell Death Dis. 2019;10:918.","journal-title":"Cell Death Dis"},{"key":"4805_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cytogfr.2025.01.001","volume":"85","author":"Wu","year":"2025","unstructured":"Wu, et al. Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy. Cytokine Growth Factor Rev. 2025;85:93\u2013102.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4805_CR45","doi-asserted-by":"publisher","first-page":"215839","DOI":"10.1016\/j.canlet.2022.215839","volume":"546","author":"Y Fang","year":"2022","unstructured":"Fang Y, et al. Cancer-associated fibroblast-like fibroblasts in vocal fold leukoplakia suppress CD8(+)T cell functions by inducing IL-6 autocrine loop and interacting with Th17 cells. Cancer Lett. 2022;546:215839.","journal-title":"Cancer Lett"},{"issue":"6","key":"4805_CR46","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.4049\/jimmunol.173.6.3844","volume":"173","author":"SJ Park","year":"2004","unstructured":"Park SJ, et al. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol. 2004;173(6):3844\u201354.","journal-title":"J Immunol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04805-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04805-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04805-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:03:37Z","timestamp":1781229817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04805-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4805"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04805-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}